Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,917.00
Bid: 1,919.00
Ask: 1,921.00
Change: -24.00 (-1.24%)
Spread: 2.00 (0.104%)
Open: 1,947.00
High: 1,956.00
Low: 1,907.00
Prev. Close: 1,941.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Rio Tinto zips higher as Reckitt Benckiser falls

Fri, 10th Feb 2017 17:10

(ShareCast News) - FTSE 100 is higher on Friday afternoon thanks to a string of mining behemoths led by Rio Tinto congregating atop the risers' list, albeit offset by a motley group of fallers led by consumer goods giant Reckitt Benckiser.London's top tier index closed 0.40% higher to 7,258.75 points. At about 16:50 GMT, shares in Rio Tinto were surging ahead after it confirmed the appointment of three oil- and energy-sector heavyweights to the boards of London-quoted Rio Tinto Plc and Australia-listed Rio Tinto Ltd.The former CEOs of Sasol Ltd and Centrica Plc, respectively David Constable and Sam Laidlaw, would be appointed with immediate effect as independent non-executive directors.Royal Dutch Shell's CFO, Simon Henry, would join the board, also as a non-executive independent director, with effect from 1 July. Two non-exec directors were leaving.Rio Tinto also benefitted alongside the wider blue-chip mining sector -- Antofagasta, Anglo American, Glencore and BHP Billiton all firmly ahead -- aided by well received macro data.The UK trade deficit narrowed to £8.6bn in the fourth quarter, from £14.1bn previously and helped by an increase in exports to countries outside the European Union, the ONS said.Separately, ONS also said UK industrial production rose 1.1% in December, helped by a hike in manufacturing. Economists expected a 0.2% rise. Manufacturing output climbed 2.1% in December, ahead of forecasts for a rise of 0.5%.Construction output edged up 1.8% month-on-month in December, compared to estimates for a 1% rise, and grew 0.6% year-on-year, compared to estimates for a 0.5% fall.Of blue chips retreating, Nurofen and Durex maker Reckitt Benckiser topped the bill on saying it would buy US baby milk company Mead Johnson for up to $17.9bn, including net debt.Reckitt also said its revenue and earnings grew in 2016 despite challenging markets and products.Other sectors notably lower included pharmaceuticals behind Smith & Nephew and Hikma Pharmaceuticals.Shares in BT Group fell as reports confirmed the resignation of its continental Europe chief, Corrado Sciolla, amid the fallout of an accounting scandal at its Italian business. FTSE 100 - RisersRio Tinto (RIO) 3,572.50p 5.63%Antofagasta (ANTO) 866.00p 4.65%Anglo American (AAL) 1,352.50p 4.40%Glencore (GLEN) 320.75p 2.74%BHP Billiton (BLT) 1,370.00p 2.39%Capita (CPI) 525.00p 2.34%Rolls-Royce Holdings (RR.) 732.50p 2.02%BAE Systems (BA.) 612.00p 2.00%Old Mutual (OML) 211.20p 1.78%Fresnillo (FRES) 1,556.00p 1.77%FTSE 100 - FallersReckitt Benckiser Group (RB.) 7,025.00p -2.96%Royal Bank of Scotland Group (RBS) 228.90p -1.80%Convatec Group (CTEC) 240.30p -1.52%Smith & Nephew (SN.) 1,186.00p -1.00%Hikma Pharmaceuticals (HIK) 1,937.00p -0.92%3i Group (III) 714.50p -0.83%Sainsbury (J) (SBRY) 264.60p -0.79%Lloyds Banking Group (LLOY) 65.64p -0.76%Worldpay Group (WPG) 272.00p -0.73%Vodafone Group (VOD) 197.70p -0.70%
More News
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more
30 Apr 2021 07:57

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises

Read more
30 Apr 2021 07:38

Hikma predicts generics revenue at top of guidance

(Sharecast News) - Hikma Pharmaceutical said it made a good start to 2021 and that annual revenue from generic treatments would be at the top of guidance.

Read more
23 Apr 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
21 Apr 2021 12:08

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

LONDON MARKET MIDDAY: Stocks recover modestly; Netflix misses targets

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more
21 Apr 2021 09:01

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

LONDON MARKET OPEN: Stocks rise; Just Eat sinks on Germany competition

Read more
21 Apr 2021 07:52

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

LONDON MARKET PRE-OPEN: Anto holds outlook, BHP cuts coal guidance

Read more
21 Apr 2021 07:30

Hikma resumes US launch of 'Advair Diskus' generic

(Sharecast News) - Hikma Pharmaceuticals has resumed the launch of its generic version of GlaxoSmithKline's 'Advair Diskus' in the United States, it announced on Wednesday, following Food and Drug Administration (FDA) approval of an amendment it submitted to its Abbreviated New Drug Application in January.

Read more
19 Apr 2021 16:02

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.